ID   K1C19_HUMAN             Reviewed;         400 AA.
AC   P08727; B2R874; Q5XG83; Q6NW33; Q7L5M9; Q96A53; Q96FV1; Q9BYF9; Q9P1Y4;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 4.
DT   28-JUN-2023, entry version 222.
DE   RecName: Full=Keratin, type I cytoskeletal 19;
DE   AltName: Full=Cytokeratin-19;
DE            Short=CK-19;
DE   AltName: Full=Keratin-19;
DE            Short=K19;
GN   Name=KRT19;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT GLY-60.
RC   TISSUE=Placenta;
RX   PubMed=2447559; DOI=10.1093/nar/15.23.10058;
RA   Stasiak P.C., Lane E.B.;
RT   "Sequence of cDNA coding for human keratin 19.";
RL   Nucleic Acids Res. 15:10058-10058(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND TISSUE SPECIFICITY.
RX   PubMed=2468493;
RA   Bader B.L., Jahn L., Franke W.W.;
RT   "Low level expression of cytokeratins 8, 18 and 19 in vascular smooth
RT   muscle cells of human umbilical cord and in cultured cells derived
RT   therefrom, with an analysis of the chromosomal locus containing the
RT   cytokeratin 19 gene.";
RL   Eur. J. Cell Biol. 47:300-319(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLY-60.
RX   PubMed=2448790; DOI=10.1073/pnas.85.4.1114;
RA   Eckert R.L.;
RT   "Sequence of the human 40-kDa keratin reveals an unusual structure with
RT   very high sequence identity to the corresponding bovine keratin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:1114-1118(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND
RP   VARIANT GLY-60.
RC   TISSUE=Placenta;
RX   PubMed=2469734; DOI=10.1111/1523-1747.ep12721500;
RA   Stasiak P.C., Purkis P.E., Leigh I.M., Lane E.B.;
RT   "Keratin 19: predicted amino acid sequence and broad tissue distribution
RT   suggest it evolved from keratinocyte keratins.";
RL   J. Invest. Dermatol. 92:707-716(1989).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT GLY-60.
RX   PubMed=10623642; DOI=10.1006/bbrc.1999.1966;
RA   Whittock N.V., Eady R.A.J., McGrath J.A.;
RT   "Genomic organization and amplification of the human keratin 15 and 19
RT   genes.";
RL   Biochem. Biophys. Res. Commun. 267:462-465(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLY-60.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLY-60.
RC   TISSUE=Mammary gland, Pancreas, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-9.
RC   TISSUE=Peripheral blood leukocyte;
RX   PubMed=11682035; DOI=10.1016/s0168-8278(01)00167-2;
RA   Kagaya M., Kaneko S., Ohno H., Inamura K., Kobayashi K.;
RT   "Cloning and characterization of the 5'-flanking region of human
RT   cytokeratin 19 gene in human cholangiocarcinoma cell line.";
RL   J. Hepatol. 35:504-511(2001).
RN   [10]
RP   PROTEIN SEQUENCE OF 25-31; 151-158 AND 227-237.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel protein
RT   database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 145-352.
RC   TISSUE=Lymph node;
RA   Sato T., Weerasinghe A., Kuwano Y., Kaneko T., Ikeda T., Nagai T.,
RA   Makino H., Sano M., Honma K., Nemoto K., Abo T., Shima Y.;
RT   "Diversity of keratin 19 gene expressed in lymph nodes of breast cancer
RT   patients -- strategy to clear the discrepancy between histological findings
RT   and RT-PCR results in the detection of micrometastasis.";
RL   Seibutsu Butsuri Kagaku 44:201-204(2000).
RN   [12]
RP   PHOSPHORYLATION AT SER-35, AND MUTAGENESIS OF SER-10 AND SER-35.
RX   PubMed=10212274; DOI=10.1074/jbc.274.18.12861;
RA   Zhou X., Liao J., Hu L., Feng L., Omary M.B.;
RT   "Characterization of the major physiologic phosphorylation site of human
RT   keratin 19 and its role in filament organization.";
RL   J. Biol. Chem. 274:12861-12866(1999).
RN   [13]
RP   INTERACTION WITH PNN.
RX   PubMed=10809736; DOI=10.1074/jbc.275.20.14910;
RA   Shi J., Sugrue S.P.;
RT   "Dissection of protein linkage between keratins and pinin, a protein with
RT   dual location at desmosome-intermediate filament complex and in the
RT   nucleus.";
RL   J. Biol. Chem. 275:14910-14915(2000).
RN   [14]
RP   INTERACTION WITH HEPATITIS C VIRUS CORE PROTEIN (MICROBIAL INFECTION).
RX   PubMed=15846844; DOI=10.1002/pmic.200401093;
RA   Kang S.-M., Shin M.-J., Kim J.-H., Oh J.-W.;
RT   "Proteomic profiling of cellular proteins interacting with the hepatitis C
RT   virus core protein.";
RL   Proteomics 5:2227-2237(2005).
RN   [15]
RP   FUNCTION, INTERACTION WITH DMD, AND TISSUE SPECIFICITY.
RX   PubMed=16000376; DOI=10.1091/mbc.e05-02-0112;
RA   Stone M.R., O'Neill A., Catino D., Bloch R.J.;
RT   "Specific interaction of the actin-binding domain of dystrophin with
RT   intermediate filaments containing keratin 19.";
RL   Mol. Biol. Cell 16:4280-4293(2005).
RN   [16]
RP   PHOSPHORYLATION AT TYR-391.
RX   PubMed=21049038; DOI=10.1371/journal.pone.0013538;
RA   Zhou Q., Snider N.T., Liao J., Li D.H., Hong A., Ku N.O., Cartwright C.A.,
RA   Omary M.B.;
RT   "Characterization of in vivo keratin 19 phosphorylation on tyrosine-391.";
RL   PLoS ONE 5:E13538-E13538(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14; SER-22; THR-323; SER-395
RP   AND SER-397, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-7; ARG-24; ARG-32; ARG-43 AND
RP   ARG-51, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [20]
RP   VARIANT [LARGE SCALE ANALYSIS] GLY-60, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Involved in the organization of myofibers. Together with
CC       KRT8, helps to link the contractile apparatus to dystrophin at the
CC       costameres of striated muscle. {ECO:0000269|PubMed:16000376}.
CC   -!- SUBUNIT: Heterotetramer of two type I and two type II keratins.
CC       Interacts with PNN and the actin-binding domain of DMD. Interacts with
CC       HCV core protein. {ECO:0000269|PubMed:10809736,
CC       ECO:0000269|PubMed:16000376}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with hepatitis C virus/HCV
CC       core protein. {ECO:0000269|PubMed:15846844}.
CC   -!- INTERACTION:
CC       P08727; Q9NYB9: ABI2; NbExp=3; IntAct=EBI-742756, EBI-743598;
CC       P08727; Q9NYB9-2: ABI2; NbExp=3; IntAct=EBI-742756, EBI-11096309;
CC       P08727; A2BDD9: AMOT; NbExp=3; IntAct=EBI-742756, EBI-17286414;
CC       P08727; Q9Y2J4-4: AMOTL2; NbExp=3; IntAct=EBI-742756, EBI-10187270;
CC       P08727; P40617: ARL4A; NbExp=3; IntAct=EBI-742756, EBI-2875746;
CC       P08727; Q9Y5Z0: BACE2; NbExp=3; IntAct=EBI-742756, EBI-11282723;
CC       P08727; Q9BXY8: BEX2; NbExp=3; IntAct=EBI-742756, EBI-745073;
CC       P08727; Q9NX04: C1orf109; NbExp=6; IntAct=EBI-742756, EBI-8643161;
CC       P08727; Q9H257: CARD9; NbExp=4; IntAct=EBI-742756, EBI-751319;
CC       P08727; Q8IYE0-2: CCDC146; NbExp=3; IntAct=EBI-742756, EBI-10247802;
CC       P08727; Q8TD31-3: CCHCR1; NbExp=3; IntAct=EBI-742756, EBI-10175300;
CC       P08727; Q8IYX8-2: CEP57L1; NbExp=3; IntAct=EBI-742756, EBI-10181988;
CC       P08727; P28329-3: CHAT; NbExp=3; IntAct=EBI-742756, EBI-25837549;
CC       P08727; Q9BT78: COPS4; NbExp=3; IntAct=EBI-742756, EBI-742413;
CC       P08727; P09172: DBH; NbExp=3; IntAct=EBI-742756, EBI-8589586;
CC       P08727; P11532: DMD; NbExp=2; IntAct=EBI-742756, EBI-295827;
CC       P08727; O60573: EIF4E2; NbExp=3; IntAct=EBI-742756, EBI-398610;
CC       P08727; Q9NRA8: EIF4ENIF1; NbExp=3; IntAct=EBI-742756, EBI-301024;
CC       P08727; Q8IYI6: EXOC8; NbExp=4; IntAct=EBI-742756, EBI-742102;
CC       P08727; Q9H5Z6: FAM124B; NbExp=3; IntAct=EBI-742756, EBI-741626;
CC       P08727; P22607: FGFR3; NbExp=3; IntAct=EBI-742756, EBI-348399;
CC       P08727; P14136: GFAP; NbExp=9; IntAct=EBI-742756, EBI-744302;
CC       P08727; Q8IVS8: GLYCTK; NbExp=3; IntAct=EBI-742756, EBI-748515;
CC       P08727; P06396: GSN; NbExp=3; IntAct=EBI-742756, EBI-351506;
CC       P08727; Q96CS2: HAUS1; NbExp=3; IntAct=EBI-742756, EBI-2514791;
CC       P08727; O14964: HGS; NbExp=4; IntAct=EBI-742756, EBI-740220;
CC       P08727; P01112: HRAS; NbExp=3; IntAct=EBI-742756, EBI-350145;
CC       P08727; O43464: HTRA2; NbExp=3; IntAct=EBI-742756, EBI-517086;
CC       P08727; P42858: HTT; NbExp=6; IntAct=EBI-742756, EBI-466029;
CC       P08727; Q9UKT9: IKZF3; NbExp=3; IntAct=EBI-742756, EBI-747204;
CC       P08727; Q8WXH2: JPH3; NbExp=3; IntAct=EBI-742756, EBI-1055254;
CC       P08727; Q9BVG8: KIFC3; NbExp=3; IntAct=EBI-742756, EBI-2125614;
CC       P08727; Q92876: KLK6; NbExp=3; IntAct=EBI-742756, EBI-2432309;
CC       P08727; P04264: KRT1; NbExp=3; IntAct=EBI-742756, EBI-298429;
CC       P08727; P35908: KRT2; NbExp=10; IntAct=EBI-742756, EBI-1247312;
CC       P08727; P12035: KRT3; NbExp=3; IntAct=EBI-742756, EBI-2430095;
CC       P08727; P19013: KRT4; NbExp=3; IntAct=EBI-742756, EBI-2371606;
CC       P08727; P13647: KRT5; NbExp=3; IntAct=EBI-742756, EBI-702187;
CC       P08727; P02538: KRT6A; NbExp=5; IntAct=EBI-742756, EBI-702198;
CC       P08727; P04259: KRT6B; NbExp=4; IntAct=EBI-742756, EBI-740907;
CC       P08727; P48668: KRT6C; NbExp=3; IntAct=EBI-742756, EBI-2564105;
CC       P08727; Q3SY84: KRT71; NbExp=3; IntAct=EBI-742756, EBI-2952676;
CC       P08727; Q14CN4: KRT72; NbExp=3; IntAct=EBI-742756, EBI-1221280;
CC       P08727; Q7RTS7: KRT74; NbExp=3; IntAct=EBI-742756, EBI-968660;
CC       P08727; O95678: KRT75; NbExp=3; IntAct=EBI-742756, EBI-2949715;
CC       P08727; Q7Z794: KRT77; NbExp=3; IntAct=EBI-742756, EBI-3045529;
CC       P08727; Q8N1N4: KRT78; NbExp=3; IntAct=EBI-742756, EBI-1056564;
CC       P08727; Q5XKE5: KRT79; NbExp=3; IntAct=EBI-742756, EBI-2514135;
CC       P08727; P05787: KRT8; NbExp=3; IntAct=EBI-742756, EBI-297852;
CC       P08727; Q6KB66-2: KRT80; NbExp=5; IntAct=EBI-742756, EBI-11999246;
CC       P08727; Q14533: KRT81; NbExp=3; IntAct=EBI-742756, EBI-739648;
CC       P08727; P78385: KRT83; NbExp=3; IntAct=EBI-742756, EBI-10221390;
CC       P08727; P78386: KRT85; NbExp=3; IntAct=EBI-742756, EBI-1049371;
CC       P08727; O43790: KRT86; NbExp=3; IntAct=EBI-742756, EBI-9996498;
CC       P08727; Q96BZ8: LENG1; NbExp=3; IntAct=EBI-742756, EBI-726510;
CC       P08727; Q8TCE9: LGALS14; NbExp=3; IntAct=EBI-742756, EBI-10274069;
CC       P08727; P07196: NEFL; NbExp=3; IntAct=EBI-742756, EBI-475646;
CC       P08727; Q8NI38: NFKBID; NbExp=3; IntAct=EBI-742756, EBI-10271199;
CC       P08727; Q9Y5F1: PCDHB12; NbExp=3; IntAct=EBI-742756, EBI-12012016;
CC       P08727; Q16512: PKN1; NbExp=3; IntAct=EBI-742756, EBI-602382;
CC       P08727; Q9UGP5-2: POLL; NbExp=3; IntAct=EBI-742756, EBI-10320765;
CC       P08727; O15160: POLR1C; NbExp=3; IntAct=EBI-742756, EBI-1055079;
CC       P08727; Q6NYC8: PPP1R18; NbExp=3; IntAct=EBI-742756, EBI-2557469;
CC       P08727; P05129: PRKCG; NbExp=3; IntAct=EBI-742756, EBI-949799;
CC       P08727; P41219: PRPH; NbExp=6; IntAct=EBI-742756, EBI-752074;
CC       P08727; P25786: PSMA1; NbExp=3; IntAct=EBI-742756, EBI-359352;
CC       P08727; Q9P2K3-2: RCOR3; NbExp=3; IntAct=EBI-742756, EBI-1504830;
CC       P08727; Q96ES7: SGF29; NbExp=5; IntAct=EBI-742756, EBI-743117;
CC       P08727; Q969G3: SMARCE1; NbExp=3; IntAct=EBI-742756, EBI-455078;
CC       P08727; O95295: SNAPIN; NbExp=3; IntAct=EBI-742756, EBI-296723;
CC       P08727; Q9NZD8: SPG21; NbExp=3; IntAct=EBI-742756, EBI-742688;
CC       P08727; Q9P0N9: TBC1D7; NbExp=7; IntAct=EBI-742756, EBI-3258000;
CC       P08727; Q9BT92: TCHP; NbExp=3; IntAct=EBI-742756, EBI-740781;
CC       P08727; P0C1Z6-2: TFPT; NbExp=3; IntAct=EBI-742756, EBI-10178002;
CC       P08727; P21980: TGM2; NbExp=2; IntAct=EBI-742756, EBI-727668;
CC       P08727; Q7KZS0: UBE2I; NbExp=3; IntAct=EBI-742756, EBI-10180829;
CC       P08727; O76024: WFS1; NbExp=3; IntAct=EBI-742756, EBI-720609;
CC   -!- TISSUE SPECIFICITY: Expressed in a defined zone of basal keratinocytes
CC       in the deep outer root sheath of hair follicles. Also observed in sweat
CC       gland and mammary gland ductal and secretory cells, bile ducts,
CC       gastrointestinal tract, bladder urothelium, oral epithelia, esophagus,
CC       ectocervical epithelium (at protein level). Expressed in epidermal
CC       basal cells, in nipple epidermis and a defined region of the hair
CC       follicle. Also seen in a subset of vascular wall cells in both the
CC       veins and artery of human umbilical cord, and in umbilical cord
CC       vascular smooth muscle. Observed in muscle fibers accumulating in the
CC       costameres of myoplasm at the sarcolemma in structures that contain
CC       dystrophin and spectrin. {ECO:0000269|PubMed:16000376,
CC       ECO:0000269|PubMed:2468493, ECO:0000269|PubMed:2469734}.
CC   -!- DEVELOPMENTAL STAGE: Present in hair follicles at all stages of
CC       development. {ECO:0000269|PubMed:2469734}.
CC   -!- DOMAIN: This keratin differs from all other IF proteins in lacking the
CC       C-terminal tail domain.
CC   -!- MISCELLANEOUS: There are two types of cytoskeletal and microfibrillar
CC       keratin: I (acidic; 40-55 kDa) and II (neutral to basic; 56-70 kDa).
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01188}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J03607; AAA36044.1; -; Genomic_DNA.
DR   EMBL; Y00503; CAA68556.1; -; mRNA.
DR   EMBL; AF202321; AAF27048.1; -; Genomic_DNA.
DR   EMBL; AK313261; BAG36071.1; -; mRNA.
DR   EMBL; AC019349; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002539; AAH02539.3; -; mRNA.
DR   EMBL; BC007628; AAH07628.1; -; mRNA.
DR   EMBL; BC010409; AAH10409.3; -; mRNA.
DR   EMBL; BC067744; AAH67744.2; -; mRNA.
DR   EMBL; BC084574; AAH84574.2; -; mRNA.
DR   EMBL; AB045973; BAB40770.1; -; Genomic_DNA.
DR   EMBL; AB041267; BAA94607.1; -; mRNA.
DR   CCDS; CCDS11399.1; -.
DR   PIR; A31370; KRHU9.
DR   RefSeq; NP_002267.2; NM_002276.4.
DR   AlphaFoldDB; P08727; -.
DR   SMR; P08727; -.
DR   BioGRID; 110078; 263.
DR   DIP; DIP-35655N; -.
DR   IntAct; P08727; 96.
DR   MINT; P08727; -.
DR   STRING; 9606.ENSP00000355124; -.
DR   GlyGen; P08727; 3 sites, 1 O-linked glycan (3 sites).
DR   iPTMnet; P08727; -.
DR   PhosphoSitePlus; P08727; -.
DR   SwissPalm; P08727; -.
DR   BioMuta; KRT19; -.
DR   DMDM; 311033484; -.
DR   SWISS-2DPAGE; P08727; -.
DR   CPTAC; CPTAC-1522; -.
DR   CPTAC; CPTAC-1523; -.
DR   EPD; P08727; -.
DR   jPOST; P08727; -.
DR   MassIVE; P08727; -.
DR   MaxQB; P08727; -.
DR   PaxDb; P08727; -.
DR   PeptideAtlas; P08727; -.
DR   PRIDE; P08727; -.
DR   ProteomicsDB; 52162; -.
DR   ABCD; P08727; 1 sequenced antibody.
DR   Antibodypedia; 1224; 3539 antibodies from 56 providers.
DR   DNASU; 3880; -.
DR   Ensembl; ENST00000361566.7; ENSP00000355124.3; ENSG00000171345.13.
DR   GeneID; 3880; -.
DR   KEGG; hsa:3880; -.
DR   MANE-Select; ENST00000361566.7; ENSP00000355124.3; NM_002276.5; NP_002267.2.
DR   UCSC; uc002hxd.5; human.
DR   AGR; HGNC:6436; -.
DR   CTD; 3880; -.
DR   DisGeNET; 3880; -.
DR   GeneCards; KRT19; -.
DR   HGNC; HGNC:6436; KRT19.
DR   HPA; ENSG00000171345; Tissue enhanced (esophagus, salivary gland, urinary bladder).
DR   MIM; 148020; gene.
DR   neXtProt; NX_P08727; -.
DR   OpenTargets; ENSG00000171345; -.
DR   PharmGKB; PA30225; -.
DR   VEuPathDB; HostDB:ENSG00000171345; -.
DR   eggNOG; ENOG502QV0B; Eukaryota.
DR   GeneTree; ENSGT00940000155258; -.
DR   HOGENOM; CLU_012560_8_1_1; -.
DR   InParanoid; P08727; -.
DR   OMA; YWATIND; -.
DR   OrthoDB; 4640531at2759; -.
DR   PhylomeDB; P08727; -.
DR   TreeFam; TF332742; -.
DR   PathwayCommons; P08727; -.
DR   Reactome; R-HSA-6805567; Keratinization.
DR   Reactome; R-HSA-6809371; Formation of the cornified envelope.
DR   SignaLink; P08727; -.
DR   SIGNOR; P08727; -.
DR   BioGRID-ORCS; 3880; 10 hits in 1151 CRISPR screens.
DR   ChiTaRS; KRT19; human.
DR   GeneWiki; Keratin_19; -.
DR   GenomeRNAi; 3880; -.
DR   Pharos; P08727; Tbio.
DR   PRO; PR:P08727; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; P08727; protein.
DR   Bgee; ENSG00000171345; Expressed in palpebral conjunctiva and 160 other tissues.
DR   ExpressionAtlas; P08727; baseline and differential.
DR   Genevisible; P08727; HS.
DR   GO; GO:0016327; C:apicolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0071944; C:cell periphery; IDA:MGI.
DR   GO; GO:0043034; C:costamere; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005882; C:intermediate filament; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IDA:CACAO.
DR   GO; GO:0042383; C:sarcolemma; IEA:Ensembl.
DR   GO; GO:1990357; C:terminal web; IEA:Ensembl.
DR   GO; GO:0030018; C:Z disc; IEA:Ensembl.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc.
DR   GO; GO:0008307; F:structural constituent of muscle; IDA:UniProtKB.
DR   GO; GO:0060706; P:cell differentiation involved in embryonic placenta development; IEA:Ensembl.
DR   GO; GO:0030855; P:epithelial cell differentiation; IBA:GO_Central.
DR   GO; GO:0045109; P:intermediate filament organization; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:Ensembl.
DR   GO; GO:0043627; P:response to estrogen; IEP:UniProtKB.
DR   GO; GO:0045214; P:sarcomere organization; IDA:UniProtKB.
DR   Gene3D; 1.20.5.170; -; 1.
DR   Gene3D; 1.20.5.500; Single helix bin; 1.
DR   Gene3D; 1.20.5.1160; Vasodilator-stimulated phosphoprotein; 1.
DR   InterPro; IPR018039; IF_conserved.
DR   InterPro; IPR039008; IF_rod_dom.
DR   InterPro; IPR002957; Keratin_I.
DR   PANTHER; PTHR23239; INTERMEDIATE FILAMENT; 1.
DR   PANTHER; PTHR23239:SF14; KERATIN, TYPE I CYTOSKELETAL 19; 1.
DR   Pfam; PF00038; Filament; 1.
DR   PRINTS; PR01248; TYPE1KERATIN.
DR   SMART; SM01391; Filament; 1.
DR   SUPFAM; SSF64593; Intermediate filament protein, coiled coil region; 2.
DR   SUPFAM; SSF46579; Prefoldin; 1.
DR   PROSITE; PS00226; IF_ROD_1; 1.
DR   PROSITE; PS51842; IF_ROD_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil; Direct protein sequencing; Host-virus interaction;
KW   Intermediate filament; Keratin; Methylation; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..400
FT                   /note="Keratin, type I cytoskeletal 19"
FT                   /id="PRO_0000063671"
FT   DOMAIN          80..391
FT                   /note="IF rod"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01188"
FT   REGION          1..79
FT                   /note="Head"
FT   REGION          80..115
FT                   /note="Coil 1A"
FT   REGION          116..133
FT                   /note="Linker 1"
FT   REGION          134..225
FT                   /note="Coil 1B"
FT   REGION          226..248
FT                   /note="Linker 12"
FT   REGION          244..390
FT                   /note="Necessary for interaction with PNN"
FT                   /evidence="ECO:0000269|PubMed:10809736"
FT   REGION          249..387
FT                   /note="Coil 2"
FT   REGION          388..400
FT                   /note="Rod-like helical tail"
FT   SITE            267
FT                   /note="Stutter"
FT   SITE            327
FT                   /note="Stutter"
FT   MOD_RES         7
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         14
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         22
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         24
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         24
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         32
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         35
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:10212274"
FT   MOD_RES         40
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q63279"
FT   MOD_RES         43
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         51
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         57
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q63279"
FT   MOD_RES         72
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P19001"
FT   MOD_RES         323
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         391
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:21049038"
FT   MOD_RES         395
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         397
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VARIANT         60
FT                   /note="A -> G (in dbSNP:rs4602)"
FT                   /evidence="ECO:0000269|PubMed:10623642,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:2447559, ECO:0000269|PubMed:2448790,
FT                   ECO:0000269|PubMed:2469734, ECO:0007744|PubMed:21269460"
FT                   /id="VAR_014629"
FT   MUTAGEN         10
FT                   /note="S->A: No effect on phosphorylation; no functional
FT                   effect."
FT                   /evidence="ECO:0000269|PubMed:10212274"
FT   MUTAGEN         35
FT                   /note="S->A: Abolishes phosphorylation; induces perinuclear
FT                   collapse or short cytoplasmic filaments."
FT                   /evidence="ECO:0000269|PubMed:10212274"
FT   CONFLICT        350
FT                   /note="G -> A (in Ref. 1; CAA68556 and 5; AAF27048)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   400 AA;  44106 MW;  C559BBBACCE32DCB CRC64;
     MTSYSYRQSS ATSSFGGLGG GSVRFGPGVA FRAPSIHGGS GGRGVSVSSA RFVSSSSSGA
     YGGGYGGVLT ASDGLLAGNE KLTMQNLNDR LASYLDKVRA LEAANGELEV KIRDWYQKQG
     PGPSRDYSHY YTTIQDLRDK ILGATIENSR IVLQIDNARL AADDFRTKFE TEQALRMSVE
     ADINGLRRVL DELTLARTDL EMQIEGLKEE LAYLKKNHEE EISTLRGQVG GQVSVEVDSA
     PGTDLAKILS DMRSQYEVMA EQNRKDAEAW FTSRTEELNR EVAGHTEQLQ MSRSEVTDLR
     RTLQGLEIEL QSQLSMKAAL EDTLAETEAR FGAQLAHIQA LISGIEAQLG DVRADSERQN
     QEYQRLMDIK SRLEQEIATY RSLLEGQEDH YNNLSASKVL
//
